Triglyceride clearance in subjects with heterozygous EXT1 or EXT2 Mutations

• Conditions: hypertriglyceridemie; Hereditary Multiple Exostosis; Multiple Osteochondroma

• Registration Number: NL-OMON33207
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

HME/MO or familyrelatedness to HME/MO

Exclusion Criteria

diabetes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Triglyceride clearance</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>LPL binding capacity<br /><br>Urine albumin and glycosaminoglycan profile </p><br>